Shopping Cart
Remove All
Your shopping cart is currently empty
Bortezomib-d8 is the deuterated form of Bortezomib. Bortezomib (PS-341) is a reversible and selective proteasome inhibitor that effectively targets threonine residues, inhibiting the 20S proteasome (Ki=0.6 nM). It disrupts the cell cycle, induces apoptosis, and inhibits the nuclear factor NF-κB. Bortezomib is noted as the first proteasome inhibitor with anticancer activity.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Bortezomib-d8 is the deuterated form of Bortezomib. Bortezomib (PS-341) is a reversible and selective proteasome inhibitor that effectively targets threonine residues, inhibiting the 20S proteasome (Ki=0.6 nM). It disrupts the cell cycle, induces apoptosis, and inhibits the nuclear factor NF-κB. Bortezomib is noted as the first proteasome inhibitor with anticancer activity. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.